Identity
- Security key
- 14924
- Ticker
- ESLAW
- Type
- WARRANT — Warrant
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2023-10-02
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ESLA / W
Detail
Enriched 2026-08-14 20:47
- Market cap
- —
- Shares outstanding (class)
- 2,215,000
- Shares outstanding (weighted)
- —
- SIC
- 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Employees
- —
- Location
- EMERYVILLE, CA
- Homepage
- https://www.estrellabio.com
- Description
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Market cap and share counts drift.